1. Research Funding
  2. Division of Discovery Science & Technology (Bioengineering)

Division of Discovery Science & Technology (Bioengineering)

This division supports the development and demonstration of modular platform technologies and engineering approaches to manipulate and interface with biology to enable a new paradigm of biomedical intervention for human health, without preference for any disease or application.

Program Areas: Early-Stage Innovation Cluster

Biochemical Engineering

Luisa Russell, Ph.D.

Bioelectromagnetic Engineering

Moria Fisher Bittmann, Ph.D.

Biomechanical Engineering

Moria Fisher Bittmann, Ph.D.

Biophotonic Engineering

David Rampulla, Ph.D.

Biomimetic Systems

Luisa Russell, Ph.D.

Rehabilitation Engineering

Michael Wolfson, Ph.D.

Mathematical Modeling

Grace C.Y. Peng, Ph.D.

Robotic Systems

Moria Fisher Bittmann, Ph.D.

Synthetic Biological Systems

David Rampulla, Ph.D.

Program Areas: Translation and Commercialization Cluster

Resource Centers for Bioengineering Technologies

Ilana Goldberg, Ph.D.

Small Business

Ilana Goldberg, Ph.D.

Collaborations

An important aspect of the Institute’s mission is encouraging collaborations among the institutes and centers at NIH, other federal agencies, and the private sector.

  • Interagency Modeling and Analysis Group (IMAG) – IMAG brings together program officers across federal agencies to communicate, disseminate, and plan collaborative activities and joint initiatives related to computational and analytical modeling and analysis of biomedical, biological, and behavioral systems, see IMAG Research. IMAG also hosts the NIH Population Modeling Scientific Interest Group and the Multi-scale Modeling (MSM) Consortium.
     
  • Synthetic Biology Consortium (SBC) - The SBC is a trans-NIH effort to foster collaborations among researchers and share synthetic biology technologies to address unmet needs in biology and medicine.

Division Staff

Related News

  • NIH-funded COVID-19 home test is first to receive over-the-counter authorization from FDA

    Press Releases ·

    hand with dropper
    The FDA granted emergency use authorization today for an innovative COVID-19 viral antigen test developed with support from the NIH RADx Initiative.

  • Engineers 3D print lifelike heart valve models

    Science Highlights ·

    3D model of aortic root
    Every year thousands of Americans, mostly over age 75, require replacement of their aortic valve. Now 3D printed patient-specific models of the aorta can aid presurgical planning and improve outcomes of minimally invasive valve replacement.

  • New CRISPR-based test for COVID-19 uses a smartphone camera

    Grantee News ·

    In a new study, a team of researchers outlines the technology for a CRISPR-based test for COVID-19 that uses a smartphone camera to provide accurate results in under 30 minutes.

  • NIH-funded tool helps organizations plan COVID-19 testing

    Press Releases ·

    laptop screen
    The COVID-19 Testing Impact Calculator is a free resource that shows how different approaches to testing and other mitigation measures, such as mask use, can curb the spread of the virus in any organization.

  • Algae breathe life into 3D engineered tissues

    Grantee News ·

    3D bioprinted algae can be harnessed as a sustainable source of oxygen for human cells in engineered vascularized tissues, researchers report. They embedded the bioprinted photosynthetic algae, along with human liver-derived cells, in a 3D hydrogel matrix to create honeycomb-shaped tissues with lobules, similar to the human liver.
View All News